Baird Financial Group
CRL icon

Baird Financial Group’s Charles River Laboratories CRL Stock Holding History

Baird Financial Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Sell
1,841
-34
-2% -$6.05K ﹤0.01% 1606
2026
Q1 		$323K Buy
1,875
+28
+2% +$5.19K ﹤0.01% 1614
2025
Q4 		$368K Sell
1,847
-22
-1% -$3.99K ﹤0.01% 1575
2025
Q3 		$292K Sell
1,869
-278
-13% -$44.2K ﹤0.01% 1648
2025
Q2 		$326K Sell
2,147
-421
-16% -$56.1K ﹤0.01% 1556
2025
Q1 		$387K Sell
2,568
-24
-0.9% -$4.02K ﹤0.01% 1468
2024
Q4 		$478K Sell
2,592
-5,494
-68% -$1.06M ﹤0.01% 1396
2024
Q3 		$1.59M Sell
8,086
-28
-0.3% -$5.82K ﹤0.01% 1030
2024
Q2 		$1.68M Buy
8,114
+2,594
+47% +$588K ﹤0.01% 1013
2024
Q1 		$1.5M Buy
5,520
+3,247
+143% +$775K ﹤0.01% 1035
2023
Q4 		$537K Buy
2,273
+197
+9% +$38.7K ﹤0.01% 1327
2023
Q3 		$407K Buy
+2,076
New +$426K ﹤0.01% 1405
2022
Q4 		– Sell
-150,586
Closed -$29.6M – 1697
2022
Q3 		$29.6M Sell
150,586
-17,313
-10% -$3.74M 0.09% 228
2022
Q2 		$35.9M Buy
167,899
+56,069
+50% +$13.7M 0.1% 217
2022
Q1 		$31.8M Buy
111,830
+110,954
+12,666% +$34.2M 0.08% 242
2021
Q4 		$330K Sell
876
-137
-14% -$53.2K ﹤0.01% 1634
2021
Q3 		$418K Buy
+1,013
New +$421K ﹤0.01% 1540

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Baird Financial Group's CRL Position: Q2 2026 in Review

Baird Financial Group reduced its Charles River Laboratories (CRL) stake by 1.8% in Q2 2026, selling an estimated $6.05K and leaving 1,841 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

Baird Financial Group first reported a position in CRL in Q3 2021 and has held it in 17 quarters since. The position peaked at $35.9M in Q2 2022. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Baird Financial Group held 1,841 shares of Charles River Laboratories worth $418K as of Q2 2026.
  • Baird Financial Group sold 34 Charles River Laboratories shares in Q2 2026, an estimated $6.05K.
  • Charles River Laboratories made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1606 holding.
  • Baird Financial Group first reported a position in Charles River Laboratories in Q3 2021 and has held it in 17 quarters since.
  • Baird Financial Group's Charles River Laboratories position peaked at $35.9M in Q2 2022.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.